Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two that may struggle to keep up.

Two Stocks to Sell:

Textron (TXT)

Trailing 12-Month GAAP Operating Margin: 8.2%

Listed on the NYSE in 1947, Textron (NYSE: TXT) provides products and services in the aerospace, defense, industrial, and finance sectors.

Why Is TXT Not Exciting?

1. Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 4% over the last two years was below our standards for the industrials sector
2. Earnings per share lagged its peers over the last two years as they only grew by 4.5% annually
3. Free cash flow margin shrank by 3.4 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive

Textron is trading at $89.83 per share, or 13.8x forward P/E. Read our free research report to see why you should think twice about including TXT in your portfolio.

Orion (ORN)

Trailing 12-Month GAAP Operating Margin: 1.4%

Established in 1994, Orion (NYSE: ORN) provides construction services for marine infrastructure and industrial projects.

Why Does ORN Worry Us?

1. Backlog has dropped by 5.2% on average over the past two years, suggesting it’s losing orders as competition picks up
2. Revenue growth over the past five years was nullified by the company’s new share issuances as its earnings per share fell by 11.9% annually
3. Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of -0.7% for the last five years

Orion’s stock price of $10.39 implies a valuation ratio of 24.3x forward P/E. If you’re considering ORN for your portfolio, see our FREE research report to learn more.

One Stock to Buy:

Humana (HUM)

Trailing 12-Month GAAP Operating Margin: 2.1%

With over 80% of its revenue derived from federal government contracts, Humana (NYSE: HUM) provides health insurance plans and healthcare services to approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.

Why Are We Bullish on HUM?

1. Offerings and unique value proposition resonate with customers, as seen in its above-market 12.4% annual sales growth over the last two years
2. Enormous revenue base of $129.8 billion gives it leverage over plan holders and advantageous reimbursement terms with healthcare providers
3. ROIC punches in at 33.1%, illustrating management’s expertise in identifying profitable investments

At $167.75 per share, Humana trades at 18.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.